论文信息 - Tamoxifen pharmacogenetics ofCYP2D6, CYP2C19, andSULT1A1: long term follow-up of the North Central Cancer Treatment Group 89-30-52 adjuvant trial. - 字舞流文

Tamoxifen pharmacogenetics ofCYP2D6, CYP2C19, andSULT1A1: long term follow-up of the North Central Cancer Treatment Group 89-30-52 adjuvant trial.

R. Weinshilboum | J. Black | C. Reynolds | M. Goetz | J. Ingle | V. Suman | M. Ames | A. Moyer | Stephanie L. Safgren | M. Kuffel | R. Avula | E. Perez